Robert Davis, CEO of Merck

Carey Business School welcomes Merck CEO to Johns Hopkins Health Policy Forum

Merck CEO Robert Davis discusses a range of drug policy issues, including the company's goals with climate change and economic inclusion, and the supply chain management.
October 6, 2021

Merck CEO Robert Davis discusses a range of drug policy issues, including the company's goals with climate change and economic inclusion, and the supply chain management.

Tags

RELATED CONTENT

News

professor emeritus Kathleen Sutcliffe speaking with Build for what's next banner in background
research business of health Management and Organizations

Professor Emeritus Kathleen Sutcliffe leads the way in uncertain times

Professor Emeritus Kathleen Sutcliffe blazes a trail for a generation of high-stakes organizational leadership scholars.

Emmanuel Elorm Nortey-Adom (MPH/MBA ’25) portrait
alumni success business of health

Carey alum Emmanuel Elorm Nortey-Adom earns FortyUnder40 award

Emmanuel Elorm Nortey-Adom (MPH/MBA ’25) is honored with Ghana’s FortyUnder40 Award for his contributions to advancing health systems innovation and chronic disease prevention.

a team of office staff at a large table with labtops all with hand on head thinking
research Management and Organizations societal impact business of health

U.S. employee well-being hit new low in 2024

Survey data shows that while well-being of managers and senior leaders has risen, their employees’ well-being has declined.